Biora Therapeutics (BIOR) Short Interest Ratio & Short Volume → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free BIOR Stock Alerts $0.61 +0.01 (+1.68%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Biora Therapeutics Short Interest DataCurrent Short Interest1,370,000 sharesPrevious Short Interest1,460,000 sharesChange Vs. Previous Month-6.16%Dollar Volume Sold Short$979,550.00Short Interest Ratio2.9 Days to CoverLast Record DateMay 15, 2024Outstanding Shares35,880,000 sharesFloat Size35,590,000 sharesShort Percent of Float3.85%Today's Trading Volume215,523 sharesAverage Trading Volume319,902 sharesToday's Volume Vs. Average67% Short Selling Biora Therapeutics ? Sign up to receive the latest short interest report for Biora Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBIOR Short Interest Over TimeBIOR Days to Cover Over TimeBIOR Percentage of Float Shorted Over Time Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… Biora Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,370,000 shares $979,550.00 -6.2%3.9%2.9 $0.72 4/30/20241,460,000 shares $956,884.00 +4.3%4.5%3.3 $0.66 4/15/20241,400,000 shares $868,000.00 +4.5%4.3%3.2 $0.62 3/31/20241,340,000 shares $1.47 million +13.6%4.2%2.9 $1.10 3/15/20241,180,000 shares $1.32 million +4.4%4.8%2.9 $1.12 2/29/20241,130,000 shares $1.48 million +58.1%4.6%2.6 $1.31 Get the Latest News and Ratings for BIOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024714,600 shares $578,111.40 +12.0%2.9%1.1 $0.81 1/31/2024638,300 shares $600,002.00 +7.8%2.5%1 $0.94 1/15/2024592,300 shares $746,298.00 +32.0%2.3%0.9 $1.26 12/31/2023448,800 shares $605,880.00 -33.5%1.7%0.8 $1.35 12/15/2023674,800 shares $917,728.00 +130.3%2.6%1.3 $1.36 11/30/2023293,000 shares $363,320.00 -55.2%1.3%0.6 $1.24 11/15/2023653,700 shares $875,958.00 +28.6%2.9%3.9 $1.34 10/31/2023508,200 shares $988,449.00 +7.4%2.3%3.8 $1.95 10/15/2023473,100 shares $865,773.00 +9.2%2.2%4.2 $1.83 9/30/2023433,300 shares $940,261.00 +38.5%2.0%4.8 $2.17 9/15/2023312,800 shares $706,928.00 +69.5%2.4%3.5 $2.26 8/31/2023184,600 shares $548,262.00 -9.0%1.5%1.6 $2.97 8/15/2023202,800 shares $636,792.00 -14.9%1.7%1.2 $3.14 7/31/2023238,300 shares $912,689.00 -12.8%1.9%1.3 $3.83 7/15/2023273,300 shares $1.09 million -26.3%2.1%1.5 $4.00 6/30/2023370,800 shares $1.43 million -9.6%2.9%2.1 $3.85 6/15/2023410,000 shares $1.75 million -0.3%3.2%2.2 $4.28 5/31/2023411,100 shares $1.84 million +5.2%3.6%2.4 $4.48 5/15/2023390,700 shares $1.31 million -7.7%3.5%2.8 $3.35 4/30/2023423,100 shares $1.03 million +0.2%3.7%3.1 $2.43 4/15/2023422,100 shares $1.10 million -0.1%4.8%1.6 $2.60 3/31/2023422,400 shares $1.17 million +24.5%4.8%0.2 $2.77 3/15/2023339,400 shares $868,864.00 -17.3%3.9%0.2 $2.56 2/28/2023410,200 shares $1.26 million -0.5%4.9%0.2 $3.06 2/15/2023412,400 shares $1.43 million -33.9%6.1%0.2 $3.46 1/31/2023623,900 shares $2.60 million -74.1%9.2%0.3 $4.17 1/15/20232,410,000 shares $10.29 million +428.5%35.4%1.1 $4.27 12/30/2022456,000 shares $37.53 million -96.1%6.7%0.5 $82.31 12/15/202211,730,000 shares $2.05 million -1.9%6.9%8.1 $0.17 11/30/202211,960,000 shares $2.93 million -7.6%7.1%9.1 $0.25 11/15/202212,950,000 shares $3.46 million -6.6%7.7%10.4 $0.27 10/31/202213,860,000 shares $5.28 million -2.5%8.4%8 $0.38 10/15/202214,210,000 shares $5.76 million +0.9%8.6%8.4 $0.41 9/30/202214,080,000 shares $6.83 million -4.4%8.5%8 $0.48Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… 9/15/202214,730,000 shares $9.95 million -0.1%8.9%7.5 $0.68 8/31/202214,750,000 shares $10.65 million -7.1%8.9%7.2 $0.72 8/15/202215,880,000 shares $16.52 million -1.2%9.6%7.4 $1.04 7/31/202216,080,000 shares $11.26 million -10.2%9.8%8.8 $0.70 7/15/202217,910,000 shares $12.57 million No Change11.0%8.2 $0.70 4/15/202220,650,000 shares $20.65 million +5.1%N/A2.3 $1.00 3/31/202219,640,000 shares $22.78 million +17.0%N/A2 $1.16 3/15/202216,790,000 shares $19.98 million -8.7%N/A1.6 $1.19 2/28/202218,380,000 shares $24.81 million +23.4%N/A1.5 $1.35 2/15/202214,900,000 shares $28.31 million +17.1%N/A0.9 $1.90 1/31/202212,720,000 shares $18.19 million -2.2%N/A0.4 $1.43 1/15/202213,000,000 shares $21.97 million -15.5%N/A0.3 $1.69 12/31/202115,380,000 shares $32.14 million -1.0%N/A0.2 $2.09 12/15/202115,530,000 shares $40.38 million -14.3%N/A0.2 $2.60 11/30/202118,130,000 shares $56.75 million +7.5%N/A0.2 $3.13 11/15/202116,860,000 shares $58.50 million -23.2%N/A0.2 $3.47 10/29/202121,960,000 shares $79.06 million -4.1%N/A0.4 $3.60 10/15/202122,890,000 shares $48.98 million +112.9%N/A0.4 $2.14 9/30/202110,750,000 shares $16.34 million +21.6%N/A0.5 $1.52 9/15/20218,840,000 shares $8.54 million +134.5%N/A1.2 $0.97 8/31/20213,770,000 shares $3.35 million +11.5%N/A0.6 $0.89 8/13/20213,380,000 shares $5.61 million +31.5%N/A0.9 $1.66 7/30/20212,570,000 shares $5.78 million -29.4%N/A1.1 $2.25 7/15/20213,640,000 shares $9.35 million -11.9%N/A1.7 $2.57 6/30/20214,130,000 shares $14.74 million -0.5%7.1%2.2 $3.57 6/15/20214,150,000 shares $13.03 million +37.4%7.2%2.6 $3.14 5/28/20213,020,000 shares $7.82 million +7.1%6.7%3.5 $2.59 5/14/20212,820,000 shares $6.63 million -10.5%6.3%6 $2.35 4/30/20213,150,000 shares $9.61 million +4.7%7.0%7.1 $3.05 4/15/20213,010,000 shares $10.54 million -3.2%6.7%6.5 $3.50 3/31/20213,110,000 shares $14.37 million +2.0%6.9%6.3 $4.62 3/15/20213,050,000 shares $14.76 million +2.0%7.0%4.4 $4.84 2/26/20212,990,000 shares $16.65 million +2.1%6.8%3.1 $5.57 2/12/20212,930,000 shares $16.47 million +3.5%7.2%3.1 $5.62 1/29/20212,830,000 shares $20.69 million +2.5%7.0%3.1 $7.31 1/15/20212,760,000 shares $14.90 million No Change6.8%3.3 $5.40 BIOR Short Interest - Frequently Asked Questions What is Biora Therapeutics' current short interest? Short interest is the volume of Biora Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 1,370,000 shares of BIOR short. 3.85% of Biora Therapeutics' shares are currently sold short. Learn More on Biora Therapeutics' current short interest. What is a good short interest ratio for Biora Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIOR shares currently have a short interest ratio of 3.0. Learn More on Biora Therapeutics's short interest ratio. Which institutional investors are shorting Biora Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Biora Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Biora Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.85% of Biora Therapeutics' floating shares are currently sold short. Is Biora Therapeutics' short interest increasing or decreasing? Biora Therapeutics saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 1,370,000 shares, a drop of 6.2% from the previous total of 1,460,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Biora Therapeutics' float size? Biora Therapeutics currently has issued a total of 35,880,000 shares. Some of Biora Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Biora Therapeutics currently has a public float of 35,590,000 shares. How does Biora Therapeutics' short interest compare to its competitors? 3.85% of Biora Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Biora Therapeutics: Lisata Therapeutics, Inc. (0.16%), Oncternal Therapeutics, Inc. (0.87%), Unity Biotechnology, Inc. (2.02%), BriaCell Therapeutics Corp. (4.29%), Bullfrog AI Holdings, Inc. (2.81%), Aprea Therapeutics, Inc. (0.68%), Cumberland Pharmaceuticals Inc. (0.37%), Enlivex Therapeutics Ltd. (1.24%), Iterum Therapeutics plc (7.70%), Apollomics, Inc. (0.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Biora Therapeutics stock? Short selling BIOR is an investing strategy that aims to generate trading profit from Biora Therapeutics as its price is falling. BIOR shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Biora Therapeutics? A short squeeze for Biora Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIOR, which in turn drives the price of the stock up even further. How often is Biora Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIOR, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: DMTK Short Interest RNLX Short Interest XGN Short Interest ENZ Short Interest IFRX Short Interest IOBT Short Interest CMRX Short Interest ONCY Short Interest ASMB Short Interest MRNS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BIOR) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.